Verona Pharma plc (VRNA): Jim Cramer Approves The Merck Acquisition
We recently published 14 Stocks Jim Cramer Discussed As He Talked About Record Bitcoin Price.
Posts Tagged ‘NASDAQ:VRNA’
14 Stocks Jim Cramer Discussed As He Talked About Record Bitcoin Price
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed the recent Bitcoin price jumps.
Verona Pharma (VRNA) Skyrockets 20.6% on $10-Billion Merger Deal with Merck
Verona Pharma surged by 20.62 percent on Wednesday to end at $104.77 per share following news that it was being acquired by US-based pharmaceutical company Merck for $10 billion...
Piper Sandler Lifts PT on Verona Pharma (VRNA) Stock, Maintains Overweight
Verona Pharma plc (NASDAQ:VRNA) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds.
11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds
As per the US Bank, the healthcare in the US exhibits a large and intricate ecosystem, which is characterized by size, complexity, and influence on the broader national economy...
Verona Pharma (VRNA) Achieved Strong Launch for Ensifentrine After FDA Approval
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” first-quarter 2025 investor letter.
Roth Capital Hikes Verona Pharma’s (VRNA) Price Target to $116 On COPD Market Prospects
Verona Pharma plc (NASDAQ:VRNA) is one of the 10 biotech stocks screaming a buy.
10 Biotech Stocks Screaming a Buy
The biotech sector has underperformed the overall market.
Jefferies Backs Verona Pharma plc (VRNA) After Strong Ohtuvayre Launch
Verona Pharma plc (NASDAQ:VRNA) is among the 10 Best Growth Stocks Under $100 to Buy Now.
10 Best Growth Stocks Under $100 to Buy Now
Even if asked by a layman where they would want to invest, the answer would be straight: growth stocks.
Jim Cramer Notes Verona Pharma plc (VRNA) “Loses a Lot of Money”
We recently published a list of Jim Cramer Put These 14 Stocks Under the Microscope.
Jim Cramer Put These 14 Stocks Under the Microscope
On Monday's episode of Mad Money, host Jim Cramer made it clear that he believes artificial intelligence remains a powerful force in the business world, especially among the largest...
11 Best Performing Healthcare Stocks to Buy Now
On April 15, CNBC reported that President Trump's healthcare-focused executive order brought in a win for the sector.
What Makes Verona Pharma plc (VRNA) a Good Investment?
Buckley Capital Advisors, an investment management company, released its first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Verona Pharma plc (NASDAQ:VRNA) Q1 2025 Earnings Call Transcript
Operator: Welcome to Verona Pharma plc's First Quarter 2025 Financial Results and Operating Highlights Conference Call.
10 Best Multibagger Stocks to Buy According to Billionaires
US Trade tariffs have triggered heightened volatility and amplified the downdraft in the equity markets.
Jim Cramer Focused On These 9 Stocks Recently
Jim Cramer, host of Mad Money, expressed his frustration on March 19 about how investors often get caught up in discussions revolving around the Federal Reserve, interest rates...
10 Best Performing Growth Stocks in 2025
Heavy AI investments and the tariffs uncertainty have been putting pressure on the technology and growth sector.
Verona Pharma plc (VRNA): A Bull Case Theory
We came across a bullish thesis on Verona Pharma plc (VRNA) on Value Investing Subreddit Page by loud_keyb. In this article, we will summarize the bulls’ thesis on VRNA.
Verona Pharma plc (NASDAQ:VRNA) Q4 2024 Earnings Call Transcript
Verona Pharma plc (NASDAQ:VRNA) Q4 2024 Earnings Call Transcript February 27, 2025Verona Pharma plc misses on earnings expectations.
10 Best Performing Pharma Stocks So Far in 2025
On February 20, Jared Holz, Mizuho healthcare sector strategist, appeared on 'Squawk Box' to discuss the potential challenges and opportunities the pharmaceutical industry may...
Billionaire Joseph Edelman’s Top 10 Long-Term Stock Picks
Joseph Edelman is a renowned figure in the investment world, recognized for his expertise in biotechnology and healthcare investing.
Verona Pharma plc (NASDAQ:VRNA) Q3 2024 Earnings Call Transcript
Verona Pharma plc (NASDAQ:VRNA) Q3 2024 Earnings Call Transcript November 4, 2024Verona Pharma plc beats earnings expectations.
Verona Pharma plc (NASDAQ:VRNA) Q2 2024 Earnings Call Transcript
Verona Pharma plc (NASDAQ:VRNA) Q2 2024 Earnings Call Transcript August 8, 2024Verona Pharma plc beats earnings expectations.
Top 10 Holdings of Caligan Partners
Founded in 2017, Caligan Partners is one of the most significant specialty hedge funds.
Verona Pharma plc (NASDAQ:VRNA) Q1 2024 Earnings Call Transcript
Operator: Hello, and welcome to Verona Pharma's First Quarter 2024 Financial Results and Operating Highlights Conference Call.
Verona Pharma plc (NASDAQ:VRNA) Q4 2023 Earnings Call Transcript
Verona Pharma plc beats earnings expectations. Reported EPS is $-0.18, expectations were $-0.23.
11 Best Undervalued UK Stocks To Buy Now
In this piece, we will take a look at the 11 best undervalued U.K. stocks to buy now.
Verona Pharma plc (NASDAQ:VRNA) Q3 2023 Earnings Call Transcript
Operator: Welcome to Verona Pharma's Third Quarter 2023 Financial Results and Operating Highlights Conference Call. At this time, all participants are in a listen-only mode.
12 Best High Risk High Reward Stocks To Buy Now
In this piece, we will take a look at the 12 best high risk high reward stocks to buy now.
Verona Pharma plc (NASDAQ:VRNA) Q2 2023 Earnings Call Transcript
Operator: Welcome to Verona Pharma Second Quarter 2023 Financial Results and Operating Highlights Conference Call. At this time all participants are in listen-only mode.
Verona Pharma plc (NASDAQ:VRNA) Q1 2023 Earnings Call Transcript
Operator: Good morning. Welcome to Verona Pharma's First Quarter 2023 Financial Results and Operating Highlights Conference Call. At this time, all participants are in a mode.
Verona Pharma plc (NASDAQ:VRNA) Q4 2022 Earnings Call Transcript
Operator: Welcome to Verona Pharma's, Fourth Quarter and Full Year 2022 Financial Results and Operating Highlights Conference Call.
12 Best Performing NASDAQ Stocks in 2022
The S&P 500 rose 0.6% to 3,844.82 on December 23, while the Nasdaq Composite gained 0.2% to close at 10,497.86.
5 Best Performing Biotech Stocks in 2022
Verona Pharma plc (NASDAQ:VRNA) is a London-based clinical stage biopharmaceutical company, focused on development and commercialization of therapies for the treatment of respiratory...
Is Verona Pharma plc (VRNA) A Good Stock To Buy?
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market...
10 Best Pharmaceutical Stocks to Buy According to Billionaire Joseph Edelman
In this article, we will discuss the 10 best pharmaceutical stocks to buy according to billionaire Joseph Edelman.
Is VRNA A Good Stock To Buy Now?
In this article we will check out the progression of hedge fund sentiment towards Verona Pharma plc (NASDAQ:VRNA) and determine whether it is a good investment right now.
25 Best U.S. Cities to Live With Asthma
Navigating through life with asthma can be a life-long challenge in itself. Sometimes it becomes very important to constantly monitor your surroundings to detect any triggers.
Is Verona Pharma plc (VRNA) A Good Stock To Buy?
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell...
Market Movers Today: Biohaven Pharmaceutical Holding Co Ltd (BHVN), Facebook, Inc. (FB), Longfin Corp (LFIN), Verona Pharma PLC – ADR (VRNA), and More
Biohaven Pharmaceutical Holding Co. Ltd.
13D Filing: OrbiMed Advisors and Verona Pharma PLC (VRNA)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of...
13G Filing: Foresite Capital Fund III, L.P. and Verona Pharma PLC (VRNA)
You can access the original SEC filing by clicking here.
